Segall Bryant & Hamill’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.33M Sell
25,197
-2,016
-7% -$370K 0.06% 313
2026
Q1
$4.35M Sell
27,213
-1,281
-4% -$197K 0.06% 318
2025
Q4
$3.91M Sell
28,494
-890
-3% -$115K 0.05% 338
2025
Q3
$3.57M Sell
29,384
-1,953
-6% -$211K 0.05% 344
2025
Q2
$3.35M Sell
31,337
-2,434
-7% -$243K 0.05% 360
2025
Q1
$3.13M Sell
33,771
-711
-2% -$68.9K 0.05% 370
2024
Q4
$3.71M Sell
34,482
-2,435
-7% -$296K 0.05% 375
2024
Q3
$4.64M Buy
36,917
+516
+1% +$64.9K 0.06% 344
2024
Q2
$3.95M Buy
+36,401
New +$3.55M 0.07% 325

Other funds holding NHC

Segall Bryant & Hamill's NHC Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its National Healthcare (NHC) stake by 7.4% in Q2 2026, selling an estimated $370K and leaving 25,197 shares worth $5.33M. The position accounts for 0.06% of the portfolio, ranked #313.

Segall Bryant & Hamill first reported a position in NHC in Q2 2024 and has held it in 9 quarters since. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Segall Bryant & Hamill held 25,197 shares of National Healthcare worth $5.33M as of Q2 2026.
  • Segall Bryant & Hamill sold 2,016 National Healthcare shares in Q2 2026, an estimated $370K.
  • National Healthcare made up 0.06% of Segall Bryant & Hamill's portfolio in Q2 2026, its #313 holding.
  • Segall Bryant & Hamill first reported a position in National Healthcare in Q2 2024 and has held it in 9 quarters since.
  • 249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.